BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12183452)

  • 21. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W; Pew T; Zou M; Pang D; Conzen SD
    J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT116 cells.
    Zhang H; Shi X; Zhang QJ; Hampong M; Paddon H; Wahyuningsih D; Pelech S
    J Biol Chem; 2002 Nov; 277(46):43648-58. PubMed ID: 12221076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase.
    Li G; Xiang Y; Sabapathy K; Silverman RH
    J Biol Chem; 2004 Jan; 279(2):1123-31. PubMed ID: 14570908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
    Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
    Clin Cancer Res; 2004 Aug; 10(15):5187-201. PubMed ID: 15297423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Isonishi S; Saitou M; Saitou M; Yasuda M; Tanaka T
    Oncol Rep; 2007 Jul; 18(1):195-201. PubMed ID: 17549368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.
    Kamath K; Wilson L; Cabral F; Jordan MA
    J Biol Chem; 2005 Apr; 280(13):12902-7. PubMed ID: 15695826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
    Mansouri A; Ridgway LD; Korapati AL; Zhang Q; Tian L; Wang Y; Siddik ZH; Mills GB; Claret FX
    J Biol Chem; 2003 May; 278(21):19245-56. PubMed ID: 12637505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism.
    Poruchynsky MS; Giannakakou P; Ward Y; Bulinski JC; Telford WG; Robey RW; Fojo T
    Biochem Pharmacol; 2001 Dec; 62(11):1469-80. PubMed ID: 11728383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tubulin from paclitaxel-resistant cells as a probe for novel antimicrotubule agents.
    Sackett DL; Giannakakou P; Poruchynsky M; Fojo A
    Cancer Chemother Pharmacol; 1997; 40(3):228-32. PubMed ID: 9219506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.
    Giannakakou P; Sackett DL; Kang YK; Zhan Z; Buters JT; Fojo T; Poruchynsky MS
    J Biol Chem; 1997 Jul; 272(27):17118-25. PubMed ID: 9202030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
    Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
    Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
    Vivo C; Liu W; Broaddus VC
    J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways.
    Wang TH; Wang HS; Ichijo H; Giannakakou P; Foster JS; Fojo T; Wimalasena J
    J Biol Chem; 1998 Feb; 273(9):4928-36. PubMed ID: 9478937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to microtubule-stabilizing drugs involves two events: beta-tubulin mutation in one allele followed by loss of the second allele.
    Wang Y; O'Brate A; Zhou W; Giannakakou P
    Cell Cycle; 2005 Dec; 4(12):1847-53. PubMed ID: 16294009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines.
    Mabuchi S; Ohmichi M; Kimura A; Nishio Y; Arimoto-Ishida E; Yada-Hashimoto N; Tasaka K; Murata Y
    Endocrinology; 2004 Jan; 145(1):49-58. PubMed ID: 14500571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma.
    Yang YM; Bost F; Charbono W; Dean N; McKay R; Rhim JS; Depatie C; Mercola D
    Clin Cancer Res; 2003 Jan; 9(1):391-401. PubMed ID: 12538493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of Raf-1 kinase is associated with paclitaxel resistance in human breast cancer MCF-7/Adr cells.
    Lee M; Koh WS; Han SS
    Cancer Lett; 2003 Apr; 193(1):57-64. PubMed ID: 12691824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.